Who invested in Avaxia Biologics?
Avaxia Biologics's investors include Cherrystone Angel, Beta Fund, LaunchPad Venture, Boston Harbor Angels and Mass Medical Angels, and 9 more on record.
United States · Venture startup
10 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$28Mraised across 10 rounds since 2011, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $1.0M sold, first sale Jul 2015
From a historical funding recordSEC filing: $3.1M sold, first sale Apr 2014
From a historical funding recordSEC filing: $2.9M sold, first sale Dec 2013
Reported by finsmes.comSEC filing: $11M sold, first sale Dec 2012
From a historical funding recordSEC filing: $4.0M sold, first sale Dec 2012
No investor was named in the report.
Reported by fis.dowjones.comSEC filing: $3.4M sold, first sale Nov 2011
Reported by finsmes.comSEC filing: $3.4M sold, first sale Nov 2011
Reported by sec.govSEC filing: $3.4M sold, first sale Nov 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Avaxia Biologics's investors include Cherrystone Angel, Beta Fund, LaunchPad Venture, Boston Harbor Angels and Mass Medical Angels, and 9 more on record.
Avaxia Biologics has raised $28M across 10 rounds since 2011. 3 rounds did not disclose an amount, so the total is a floor.
Avaxia Biologics's most recent round was a Venture of $1.0M in Jul 2015.
Avaxia Biologics's largest round on record is $12M (Series B), in Jun 2013.
Avaxia Biologics's first round on record, in Jun 2011, was backed by Cherrystone Angel.
Avaxia Biologics's latest named round is a Venture, in Jul 2015.
Avaxia Biologics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.